Senhwa Biosciences Inc(TW:6492)
NT$30.100.00 (0.00%)
TW:6492
Senhwa Biosciences Inc financials statements
NT$30.10
At close:0.00 (0.00%)
Senhwa Biosciences Inc (6492) Income Statement
Senhwa Biosciences Inc Income Statement
Last quarter (Q2 2026), Senhwa Biosciences Inc's total revenue was NT$240.00K, a decrease of 4.00% from the same quarter last year. In Q2, Senhwa Biosciences Inc's net income was NT$-82.46M. See Senhwa Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 1.07M | NT$ 1.00M | NT$ 1.00M | NT$ 1.00M | NT$ 550.00K | |
| NT$ 520.00K | NT$ 477.00K | NT$ 552.00K | NT$ -6.61M | NT$ -5.91M | |
| NT$ 278.78M | NT$ 306.67M | NT$ 311.66M | NT$ 349.51M | NT$ 340.40M | |
| Depreciation and Amortization | NT$ 12.11M | NT$ 12.10M | NT$ 10.72M | NT$ 7.11M | NT$ 6.23M |
| NT$ -266.15M | NT$ -279.71M | NT$ -283.79M | NT$ -340.60M | NT$ -321.59M | |
| NT$ -278.26M | NT$ -306.19M | NT$ -311.11M | NT$ -356.12M | NT$ -346.32M | |
| NT$ 14.82M | NT$ 13.73M | NT$ 16.07M | NT$ 7.86M | NT$ 17.97M | |
| NT$ -263.44M | NT$ -292.46M | NT$ -295.05M | NT$ -348.26M | NT$ -328.35M | |
| NT$ -264.77M | NT$ -293.75M | NT$ -296.31M | NT$ -349.63M | NT$ -329.26M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -2.97 | NT$ -3.29 | NT$ -3.32 | NT$ -3.92 | NT$ -3.67 |
| Diluted EPS | NT$ -2.97 | NT$ -3.29 | NT$ -3.32 | NT$ -3.92 | NT$ -3.67 |
| Weighted Average Shares Outstanding | 89.15M | 89.19M | 89.19M | 89.19M | 89.64M |
| Weighted Average Shares Outstanding (Diluted) | 89.15M | 89.19M | 89.19M | 89.19M | 89.64M |
Currency in TWD

